Tuesday October 23, 2018 04:20

Heathcare Press Release : 20 Dec 2017

The Best Cardio to Burn Calories Heathcare—20 Dec 17

Herbalife Nutrition's Senior Director of Worldwide Sports Performance and Fitness Samantha Clayton was in Thailand recently, as the speaker for the company's 8th Asia Pacific Wellness Tour. On this special occasion, the Football Association of Thailand

Tessa Therapeutics Closes USD 80 Million Financing Round Led by Temasek Heathcare—20 Dec 17

SINGAPORE--20 Dec--PRNewswire/InfoQuest

Tessa Therapeutics , an international clinical stage biopharmaceutical company focusing on T cell therapy for solid tumors, today announced the completion of a USD 80 million financing round led by Temasek, an investment company headquartered in Singapore, and joined by EDBI, Karst Peak Capital, Heliconia, Heritas and other investors.

Andrew Khoo, co-founder and CEO of Tessa Therapeutics, commented: "We are very pleased with the success in this financing round which validates our work and continued progress in the development of Tessa's Virus Specific T cell platform technology and clinical pipeline. Tessa plans to expand its global presence and advance next generation cellular therapies targeting a wide range of cancer indications."

Tessa will use the proceeds from this funding round to further advance its clinical pipeline and to bring new therapies, based on the company's Virus Specific T cell (VST) platform, into clinical trials.
Tessa's VST technology is showing compelling results in the treatmen

Singapore#s IP Office to Grant Merck#s Patent Application for CRISPR Heathcare—20 Dec 17

- Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR - Fourth patent allowance for Merck's CRISPR technology; similar patents from Australian, Canadian and European Patent Offices